{
  "country": "Nigeria",
  "countryIso": "NG",
  "interpretation": "Each result retains its original population, denominator, source year and method. Clinic or model estimates must not be presented as a national rate unless the original source supports that scope.",
  "observationCount": 5,
  "observations": [
    {
      "age": "Newborns",
      "caseDefinition": "Births with sickle-cell disease",
      "comparison": {
        "canCompareWithinSeries": false,
        "presentation": "descriptive"
      },
      "denominator": "Not applicable — absolute count",
      "geography": {
        "iso": "NG",
        "label": "Nigeria",
        "scope": "Studies"
      },
      "method": "GBD 2021 model: birth incidence, all-age prevalence, cause-specific mortality and total mortality among people with sickle-cell disease",
      "metric": "Births with sickle-cell disease",
      "metricId": "HDM-07065",
      "period": {
        "end": null,
        "published": "2021",
        "start": null
      },
      "population": "Live births; both sexes",
      "publishedValue": "179,000",
      "qualification": "",
      "sex": "All sexes",
      "source": {
        "id": "HDS-0263",
        "publisher": "GBD 2021 Sickle Cell Disease Collaborators",
        "title": "GBD 2021 sickle-cell disease — original appendix, Tables S9 and S13",
        "url": "https://ars.els-cdn.com/content/image/1-s2.0-S2352302623001187-mmc1.pdf"
      },
      "sourceNumericValue": 179000.0,
      "sourceVerifiedAt": null,
      "uncertainty": "95% UI 138,000–224,000",
      "unit": "affected live births"
    },
    {
      "age": "All ages",
      "caseDefinition": "People living with sickle-cell disease",
      "comparison": {
        "canCompareWithinSeries": false,
        "presentation": "descriptive"
      },
      "denominator": "Not applicable — absolute count",
      "geography": {
        "iso": "NG",
        "label": "Nigeria",
        "scope": "Studies"
      },
      "method": "GBD 2021 model: birth incidence, all-age prevalence, cause-specific mortality and total mortality among people with sickle-cell disease",
      "metric": "People living with sickle-cell disease",
      "metricId": "HDM-07066",
      "period": {
        "end": null,
        "published": "2021",
        "start": null
      },
      "population": "All ages; both sexes",
      "publishedValue": "2,590,000",
      "qualification": "",
      "sex": "All sexes",
      "source": {
        "id": "HDS-0263",
        "publisher": "GBD 2021 Sickle Cell Disease Collaborators",
        "title": "GBD 2021 sickle-cell disease — original appendix, Tables S9 and S13",
        "url": "https://ars.els-cdn.com/content/image/1-s2.0-S2352302623001187-mmc1.pdf"
      },
      "sourceNumericValue": 2590000.0,
      "sourceVerifiedAt": null,
      "uncertainty": "95% UI 2,090,000–3,220,000",
      "unit": "people"
    },
    {
      "age": "Newborns",
      "caseDefinition": "Sickle-cell disease birth incidence",
      "comparison": {
        "canCompareWithinSeries": false,
        "presentation": "descriptive"
      },
      "denominator": "Live births",
      "geography": {
        "iso": "NG",
        "label": "Nigeria",
        "scope": "Studies"
      },
      "method": "GBD 2021 model: birth incidence, all-age prevalence, cause-specific mortality and total mortality among people with sickle-cell disease",
      "metric": "Sickle-cell disease birth incidence",
      "metricId": "HDM-07969",
      "period": {
        "end": null,
        "published": "2021",
        "start": null
      },
      "population": "Live births; both sexes",
      "publishedValue": "2,290",
      "qualification": "",
      "sex": "All sexes",
      "source": {
        "id": "HDS-0263",
        "publisher": "GBD 2021 Sickle Cell Disease Collaborators",
        "title": "GBD 2021 sickle-cell disease — original appendix, Tables S9 and S13",
        "url": "https://ars.els-cdn.com/content/image/1-s2.0-S2352302623001187-mmc1.pdf"
      },
      "sourceNumericValue": 2290.0,
      "sourceVerifiedAt": null,
      "uncertainty": "95% UI 1,760–2,870",
      "unit": "per 100,000 live births"
    },
    {
      "age": "At birth (modelled)",
      "caseDefinition": "Model-estimated birth prevalence of HbSS",
      "comparison": {
        "canCompareWithinSeries": false,
        "presentation": "descriptive"
      },
      "denominator": "Modelled live births; inferred from allele frequencies in the 2018 child survey",
      "geography": {
        "iso": "NG",
        "label": "Nigeria",
        "scope": "Countries"
      },
      "method": "Hardy–Weinberg assumption near birth applied to nationally sampled 2018 NDHS genotypes",
      "metric": "Model-estimated birth prevalence of HbSS",
      "metricId": "HDM-34496",
      "period": {
        "end": 2018,
        "published": "2018",
        "start": 2018
      },
      "population": "Birth prevalence inferred from 11,186 tested children aged 6–59 months in 7,411 households",
      "publishedValue": "1.21",
      "qualification": "Model-estimated birth prevalence, not observed newborn-screening prevalence; do not equate with all-age GBD prevalence or infer a time trend.",
      "sex": "Both sexes",
      "source": {
        "id": "HDS-0356",
        "publisher": "Nnodu et al., The Lancet Haematology",
        "title": "Child mortality from sickle cell disease in Nigeria: a model-estimated, population-level analysis of data from the 2018 DHS",
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8460996/"
      },
      "sourceNumericValue": 1.21,
      "sourceVerifiedAt": "2026-11-14",
      "uncertainty": {
        "lower": 1.09,
        "type": "95% CI",
        "upper": 1.37
      },
      "unit": "% of live births"
    },
    {
      "age": "At birth (modelled)",
      "caseDefinition": "Model-estimated birth prevalence of HbSC",
      "comparison": {
        "canCompareWithinSeries": false,
        "presentation": "descriptive"
      },
      "denominator": "Modelled live births; inferred from allele frequencies in the 2018 child survey",
      "geography": {
        "iso": "NG",
        "label": "Nigeria",
        "scope": "Countries"
      },
      "method": "Hardy–Weinberg assumption near birth applied to nationally sampled 2018 NDHS genotypes",
      "metric": "Model-estimated birth prevalence of HbSC",
      "metricId": "HDM-34497",
      "period": {
        "end": 2018,
        "published": "2018",
        "start": 2018
      },
      "population": "Birth prevalence inferred from 11,186 tested children aged 6–59 months in 7,411 households",
      "publishedValue": "0.24",
      "qualification": "Model-estimated birth prevalence, not observed newborn-screening prevalence; do not equate with all-age GBD prevalence or infer a time trend.",
      "sex": "Both sexes",
      "source": {
        "id": "HDS-0356",
        "publisher": "Nnodu et al., The Lancet Haematology",
        "title": "Child mortality from sickle cell disease in Nigeria: a model-estimated, population-level analysis of data from the 2018 DHS",
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC8460996/"
      },
      "sourceNumericValue": 0.24,
      "sourceVerifiedAt": "2026-11-14",
      "uncertainty": {
        "lower": 0.19,
        "type": "95% CI",
        "upper": 0.31
      },
      "unit": "% of live births"
    }
  ],
  "pageUrl": "https://diseasesconditions.org/health/sickle-cell-disease/nigeria/",
  "parentConditionEntityId": "condition:sickle-cell-disease",
  "profileId": "health-country:sickle-cell-disease:NG",
  "representation": "verified_country_profile_observations",
  "schema": "dc-health-data-v1",
  "sourceURLs": [
    "https://ars.els-cdn.com/content/image/1-s2.0-S2352302623001187-mmc1.pdf",
    "https://pmc.ncbi.nlm.nih.gov/articles/PMC8460996/"
  ],
  "statisticalSection": "https://diseasesconditions.org/health/sickle-cell-disease/nigeria/#statistics"
}
